Ohri Manu
CIK 0001424683
Chief Financial OfficerDirector
Filings
6
Latest Mar 4, 2026
Issuers covered
2
Showing
6 of 6
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -34.8% | -34.8% | -34.8% | -34.8% |
| 90 days | 1 | 0% | -32.2% | -32.2% | -32.2% | -32.2% |
| 180 days | 1 | 0% | -48.5% | -48.5% | -48.5% | -48.5% |
| 365 days | 1 | 0% | -69.9% | -69.9% | -69.9% | -69.9% |
Issuers
Companies where Ohri Manu has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| GTBP | Gt Biopharma, Inc. | 3 | Aug 15, 2023 |
| RVIV | Reviv3 Procare Co | 3 | Mar 4, 2026 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|